In this article, Andrew Tepperman discusses a set of specific liability and damages issues that could be addressed by economic and business expert testimony. The context is assumed to be an international arbitration proceeding involving firms in the pharmaceutical industry. This article appeared in the 2015 edition of The International Comparative Legal Guide to: International Arbitration, published by Global Legal Group Ltd, London. To read the article, click the link below.
CRA recognized in GAR’s ranking with the largest average claim size among top-10 expert firms
Global Arbitration Review’s Power Index identifies the most active and sought after expert firms in international arbitration. Every year, the GAR ranks the...